Equites On the Move- Research on Aware, Biota Pharmaceuticals, Aldeyra Therapeutics and Northern Technologies
NEW YORK, NY / ACCESSWIRE / December 3, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Aware Inc. (NASDAQ: AWRE), Biota Pharmaceuticals Inc. (NASDAQ: BOTA), Aldeyra Therapeutics Inc. (NASDAQ: ALDX) and Northern Technologies International Corp. (NASDAQ: NTIC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
AWRE Research Package: http://www.traders-choice.com/pdf?s=AWRE
BOTA Research Package: http://www.traders-choice.com/pdf?s=BOTA
ALDX Research Package: http://www.traders-choice.com/pdf?s=ALDX
NTIC Research Package: http://www.traders-choice.com/pdf?s=NTIC
Highlights from today's reports include:
On Wednesday, December 02, 2015, the NASDAQ Composite ended at 5,123.22, down 0.64%, the Dow Jones Industrial Average edged 0.89% lower, to finish the day at 17,729.68, and the S&P 500 closed at 2,079.51, down 1.10%.
- Aware Inc.'s stock increased by 1.89% to close Wednesday's session at USD 3.23. The company's shares fluctuated in the range of USD 3.11 and USD 3.28 during the day. A total of 0.01 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.03 million shares. Over the last three days Aware Inc.'s shares have advanced 1.25% and in the past one week the stock has moved up 4.19%. Furthermore, over the last three months, the stock has gained 0.31% whereas in the past six months, the shares have shed 24.71%. Further, the company is trading at a price to earnings ratio of 24.53 and the stock is at a price to book ratio of 1.35. This compares to a historical PE ratio of 22.57 and a historical PB ratio close to 1.98. Additionally, the stock is trading at a price to cash flow ratio of 29.22 and at a price to sales ratio of 4.28.
- Biota Pharmaceuticals Inc.'s stock declined 1.05% to close Wednesday's session at USD 1.89. The share price vacillated between USD 1.81 and USD 1.90 in trade during the day. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.04 million shares and below its 52-week average volume of 0.10 million shares. Over the last three days Biota Pharmaceuticals Inc.'s shares have advanced 1.07% and in the past one week the stock has moved up 0.53%. However, in the last six months, the stock has lost 11.68% and year to date, the shares have shed 15.62%. The shares of the company have been trading below their 20-day and 50-day simple moving averages by 2.5% and 5.33%, respectively. Further, the stock is trading at a price to book ratio of 1.15 and at a price to sales ratio of 2.85.
- Aldeyra Therapeutics Inc.'s stock edged higher by 1.56% to close Wednesday's session at USD 7.49. The company's shares oscillated between USD 7.21 and USD 7.70 in trade during the day. The stock recorded a trading volume of 0.01 million shares, which was below its 50-day daily average volume of 0.02 million shares. Over the last three days, Aldeyra Therapeutics Inc.'s shares have advanced 6.70% and in the past one week it has moved up 8.47%. Furthermore, over the last three months, the stock has gained 4.17% whereas in the past six months, the shares have shed 4.59%. The shares of the company have been exhibiting some positive momentum and are trading above their 20-day and 50-day simple moving averages by 3.53% and 12.91%, respectively. However, they are trading below their 200-day simple moving average by 9.05%.
- The stock of Northern Technologies International Corp. lost 1.54% to close Wednesday's session at USD 16.00. The shares of the company moved in the range of USD 16.00 and USD 16.21 during the day. Over the last five days, Northern Technologies International Corp.'s shares have advanced 4.99% while in the past one month, they have lost 6.45%. Additionally, over the last three months, the stock has advanced 3.23% whereas in the past six months, the shares have registered a loss of 7.30%. Further, the company is trading at a price to earnings ratio of 41.07 and the stock is at a price to book ratio of 1.64. This compares to a historical PE ratio of 40.47 and a historical PB ratio close to 1.58. Further, the stock is trading at a price to cash flow ratio of 85.54 and at a price to sales ratio of 2.43.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice